Latest debt-to-equity ratio
Liminatus Pharma Debt-to-equity ratio
Direct answer
Liminatus Pharma's debt-to-equity ratio is 479.85%.
The verified market snapshot reports 479.85%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 20, 2026.
Get free Liminatus Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 479.85%